Cargando…

Formulation and Evaluation of Nano Lipid Carrier-Based Ocular Gel System: Optimization to Antibacterial Activity

The present research work was designed to prepare Azithromycin (AM)-loaded nano lipid carriers (NLs) for ocular delivery. NLs were prepared by the emulsification–homogenization method and further optimized by the Box Behnken design. AM-NLs were optimized using the independent constraints of homogeni...

Descripción completa

Detalles Bibliográficos
Autores principales: Gilani, Sadaf Jamal, Jumah, May Nasser bin, Zafar, Ameeduzzafar, Imam, Syed Sarim, Yasir, Mohd, Khalid, Mohammad, Alshehri, Sultan, Ghuneim, Mohammed M., Albohairy, Fatima M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140781/
https://www.ncbi.nlm.nih.gov/pubmed/35621552
http://dx.doi.org/10.3390/gels8050255
_version_ 1784715181729775616
author Gilani, Sadaf Jamal
Jumah, May Nasser bin
Zafar, Ameeduzzafar
Imam, Syed Sarim
Yasir, Mohd
Khalid, Mohammad
Alshehri, Sultan
Ghuneim, Mohammed M.
Albohairy, Fatima M.
author_facet Gilani, Sadaf Jamal
Jumah, May Nasser bin
Zafar, Ameeduzzafar
Imam, Syed Sarim
Yasir, Mohd
Khalid, Mohammad
Alshehri, Sultan
Ghuneim, Mohammed M.
Albohairy, Fatima M.
author_sort Gilani, Sadaf Jamal
collection PubMed
description The present research work was designed to prepare Azithromycin (AM)-loaded nano lipid carriers (NLs) for ocular delivery. NLs were prepared by the emulsification–homogenization method and further optimized by the Box Behnken design. AM-NLs were optimized using the independent constraints of homogenization speed (A), surfactant concentration (B), and lipid concentration (C) to obtain optimal NLs (AM-NLop). The selected AM-NLop was further converted into a sol-gel system using a mucoadhesive polymer blend of sodium alginate and hydroxyl propyl methyl cellulose (AM-NLopIG). The sol-gel system was further characterized for drug release, permeation, hydration, irritation, histopathology, and antibacterial activity. The prepared NLs showed nano-metric size particles (154.7 ± 7.3 to 352.2 ± 15.8 nm) with high encapsulation efficiency (48.8 ± 1.1 to 80.9 ± 2.9%). AM-NLopIG showed a more prolonged drug release (98.6 ± 4.6% in 24 h) than the eye drop (99.4 ± 5.3% in 3 h). The ex vivo permeation result depicted AM-NLopIG, AM-IG, and eye drop. AM-NLopIG exhibited significant higher AM permeation (60.7 ± 4.1%) than AM-IG (33.46 ± 3.04%) and eye drop (23.3 ± 3.7%). The corneal hydration was found to be 76.45%, which is within the standard limit. The histopathology and HET-CAM results revealed that the prepared formulation is safe for ocular use. The antibacterial study revealed enhanced activity from the AM-NLopIG.
format Online
Article
Text
id pubmed-9140781
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-91407812022-05-28 Formulation and Evaluation of Nano Lipid Carrier-Based Ocular Gel System: Optimization to Antibacterial Activity Gilani, Sadaf Jamal Jumah, May Nasser bin Zafar, Ameeduzzafar Imam, Syed Sarim Yasir, Mohd Khalid, Mohammad Alshehri, Sultan Ghuneim, Mohammed M. Albohairy, Fatima M. Gels Article The present research work was designed to prepare Azithromycin (AM)-loaded nano lipid carriers (NLs) for ocular delivery. NLs were prepared by the emulsification–homogenization method and further optimized by the Box Behnken design. AM-NLs were optimized using the independent constraints of homogenization speed (A), surfactant concentration (B), and lipid concentration (C) to obtain optimal NLs (AM-NLop). The selected AM-NLop was further converted into a sol-gel system using a mucoadhesive polymer blend of sodium alginate and hydroxyl propyl methyl cellulose (AM-NLopIG). The sol-gel system was further characterized for drug release, permeation, hydration, irritation, histopathology, and antibacterial activity. The prepared NLs showed nano-metric size particles (154.7 ± 7.3 to 352.2 ± 15.8 nm) with high encapsulation efficiency (48.8 ± 1.1 to 80.9 ± 2.9%). AM-NLopIG showed a more prolonged drug release (98.6 ± 4.6% in 24 h) than the eye drop (99.4 ± 5.3% in 3 h). The ex vivo permeation result depicted AM-NLopIG, AM-IG, and eye drop. AM-NLopIG exhibited significant higher AM permeation (60.7 ± 4.1%) than AM-IG (33.46 ± 3.04%) and eye drop (23.3 ± 3.7%). The corneal hydration was found to be 76.45%, which is within the standard limit. The histopathology and HET-CAM results revealed that the prepared formulation is safe for ocular use. The antibacterial study revealed enhanced activity from the AM-NLopIG. MDPI 2022-04-21 /pmc/articles/PMC9140781/ /pubmed/35621552 http://dx.doi.org/10.3390/gels8050255 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Gilani, Sadaf Jamal
Jumah, May Nasser bin
Zafar, Ameeduzzafar
Imam, Syed Sarim
Yasir, Mohd
Khalid, Mohammad
Alshehri, Sultan
Ghuneim, Mohammed M.
Albohairy, Fatima M.
Formulation and Evaluation of Nano Lipid Carrier-Based Ocular Gel System: Optimization to Antibacterial Activity
title Formulation and Evaluation of Nano Lipid Carrier-Based Ocular Gel System: Optimization to Antibacterial Activity
title_full Formulation and Evaluation of Nano Lipid Carrier-Based Ocular Gel System: Optimization to Antibacterial Activity
title_fullStr Formulation and Evaluation of Nano Lipid Carrier-Based Ocular Gel System: Optimization to Antibacterial Activity
title_full_unstemmed Formulation and Evaluation of Nano Lipid Carrier-Based Ocular Gel System: Optimization to Antibacterial Activity
title_short Formulation and Evaluation of Nano Lipid Carrier-Based Ocular Gel System: Optimization to Antibacterial Activity
title_sort formulation and evaluation of nano lipid carrier-based ocular gel system: optimization to antibacterial activity
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140781/
https://www.ncbi.nlm.nih.gov/pubmed/35621552
http://dx.doi.org/10.3390/gels8050255
work_keys_str_mv AT gilanisadafjamal formulationandevaluationofnanolipidcarrierbasedoculargelsystemoptimizationtoantibacterialactivity
AT jumahmaynasserbin formulationandevaluationofnanolipidcarrierbasedoculargelsystemoptimizationtoantibacterialactivity
AT zafarameeduzzafar formulationandevaluationofnanolipidcarrierbasedoculargelsystemoptimizationtoantibacterialactivity
AT imamsyedsarim formulationandevaluationofnanolipidcarrierbasedoculargelsystemoptimizationtoantibacterialactivity
AT yasirmohd formulationandevaluationofnanolipidcarrierbasedoculargelsystemoptimizationtoantibacterialactivity
AT khalidmohammad formulationandevaluationofnanolipidcarrierbasedoculargelsystemoptimizationtoantibacterialactivity
AT alshehrisultan formulationandevaluationofnanolipidcarrierbasedoculargelsystemoptimizationtoantibacterialactivity
AT ghuneimmohammedm formulationandevaluationofnanolipidcarrierbasedoculargelsystemoptimizationtoantibacterialactivity
AT albohairyfatimam formulationandevaluationofnanolipidcarrierbasedoculargelsystemoptimizationtoantibacterialactivity